Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 562

1.

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ.

AIDS. 2004 May 21;18(8):1169-77.

PMID:
15166532
[PubMed - indexed for MEDLINE]
2.

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.

Lincoln D, Petoumenos K, Dore GJ; Australian HIV Observational Database.

HIV Med. 2003 Jul;4(3):241-9.

PMID:
12859323
[PubMed - indexed for MEDLINE]
3.

Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.

Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC.

Int J STD AIDS. 2005 Jan;16(1):42-8.

PMID:
15705272
[PubMed - indexed for MEDLINE]
4.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
[PubMed - indexed for MEDLINE]
5.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.

AIDS. 2006 May 12;20(8):1171-9.

PMID:
16691069
[PubMed - indexed for MEDLINE]
6.

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL.

JAMA. 2002 Jul 10;288(2):199-206.

PMID:
12095384
[PubMed - indexed for MEDLINE]
7.

Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.

Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N.

HIV Med. 2008 May;9(5):300-6. doi: 10.1111/j.1468-1293.2008.00564.x.

PMID:
18400077
[PubMed - indexed for MEDLINE]
8.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
[PubMed - indexed for MEDLINE]
Free Article
9.

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.

Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N.

Clin Infect Dis. 2006 May 15;42(10):1481-7. Epub 2006 Apr 12.

PMID:
16619163
[PubMed - indexed for MEDLINE]
Free Article
10.

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.

Duncombe C, Kerr SJ, Ruxrungtham K, Dore GJ, Law MG, Emery S, Lange JM, Phanuphak P, Cooper DA.

AIDS. 2005 Jan 28;19(2):169-78.

PMID:
15668542
[PubMed - indexed for MEDLINE]
11.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

JAMA. 1999 Dec 15;282(23):2220-6.

PMID:
10605973
[PubMed - indexed for MEDLINE]
12.

A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.

lsa SE, Gwamzhi LN, Akolo C, Giyan J.

Niger J Med. 2010 Jul-Sep;19(3):279-85.

PMID:
20845631
[PubMed - indexed for MEDLINE]
13.

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A.

Lancet. 2000 Nov 25;356(9244):1800-5. Erratum in: Lancet. 2001 May 12;357(9267):1536.

PMID:
11117912
[PubMed - indexed for MEDLINE]
14.

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.

PMID:
16107951
[PubMed - indexed for MEDLINE]
Free Article
15.

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

Clin Infect Dis. 2005 Mar 15;40(6):859-67. Epub 2005 Feb 18.

PMID:
15736020
[PubMed - indexed for MEDLINE]
Free Article
16.

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, Grappin M, Buisson M, Waldner A, Portier H, Chavanet P.

AIDS. 1998 Mar 5;12(4):381-8.

PMID:
9520167
[PubMed - indexed for MEDLINE]
17.

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.

Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE; AIDS Clinical Trials Group 383 Study Team.

AIDS. 2002 Sep 27;16(14):1915-23.

PMID:
12351951
[PubMed - indexed for MEDLINE]
18.

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study.

Bonacini M, Louie S, Bzowej N, Wohl AR.

AIDS. 2004 Oct 21;18(15):2039-45.

PMID:
15577625
[PubMed - indexed for MEDLINE]
19.

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.

Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E.

BMC Public Health. 2010 Mar 1;10:105. doi: 10.1186/1471-2458-10-105.

PMID:
20193053
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy.

Sabin CA, Yee TT, Devereux H, Griffioen A, Loveday C, Phillips AN, Lee CA.

AIDS. 2000 May 26;14(8):1001-7.

PMID:
10853982
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk